Phoebus Medical Technology, an artificial intelligence-based chronic disease management company, has raised tens of millions of RMB in series A round of financing from healthcare and life sciences-focused Cenova Capital, according to Chinese media reports.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.
Register Basic AccountSubscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!
More Info
Already have an account or paid subscription? Log in
